HIV Citation List: January 18 - January 31, 2013

PubMed citations

1. Polyphenols: A Diverse Class of Multi-target anti-HIV-1 Agents. Andrae-Marobela, K., F.W. Ghislain, H. Okatch, and R.R. Majinda. Current Drug Metabolism, 2013. [Epub ahead of print]. PMID[23330927].
[PubMed]. HIV_0118-013113.

2. High-throughput Virtual Screening of Phloroglucinol Derivatives against HIV-Reverse Transcriptase. Belekar, V., A. Shah, and P. Garg. Molecular Diversity, 2013. [Epub ahead of print]. PMID[23338523].
[PubMed]. HIV_0118-013113.

3. Identification of the Potential Regions of Epap-1 That Interacts with V3 Loop of HIV-1 gp120. Bhaskar, C., P.S. Reddy, K.S. Chandra, S. Sabde, D. Mitra, and A.K. Kondapi. Biochimica et Biophysica Acta, 2013. [Epub ahead of print]. PMID[23360764].
[PubMed]. HIV_0118-013113.

4. An Ancestral HIV-2/SIV Peptide with Potent HIV-1 and HIV-2 Fusion Inhibitor Activity. Borrego, P., R. Calado, J.M. Marcelino, P. Pereira, A. Quintas, H. Barroso, and N. Taveira. AIDS, 2013. [Epub ahead of print]. PMID[23324659].
[PubMed]. HIV_0118-013113.

5. Contribution of SUMO-interacting Motifs and SUMOylation to the Antiretroviral Properties of TRIM5alpha. Brandariz-Nunez, A., A. Roa, J.C. Valle-Casuso, N. Biris, D. Ivanov, and F. Diaz-Griffero. Virology, 2013. 435(2): p. 463-471. PMID[23084420].
[PubMed]. HIV_0118-013113.

6. Two New Derivatives of 2, 5-Dihydroxyphenylacetic acid from the Kernel of Entada phaseoloides. Chen, L., Y. Zhang, G. Ding, M. Ba, Y. Guo, and Z. Zou. Molecules, 2013. 18(2): p. 1477-1482. PMID[23353120].
[PubMed]. HIV_0118-013113.

7. Recent Advances of Diaryl Ether Family as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Chen, X., S. Ding, P. Zhan, and X. Liu. Current Pharmaceutical Design, 2013. [Epub ahead of print]. PMID[23343121].
[PubMed]. HIV_0118-013113.

8. HIV-1 Fusion Is Blocked through Binding of GB Virus C E2D Peptides to the HIV-1 gp41 Disulfide Loop. Eissmann, K., S. Mueller, H. Sticht, S. Jung, P. Zou, S. Jiang, A. Gross, J. Eichler, B. Fleckenstein, and H. Reil. PloS One, 2013. 8(1): p. e54452. PMID[23349893].
[PubMed]. HIV_0118-013113.

9. PXR/CYP3A4-humanized Mice for Studying Drug-drug Interactions Involving Intestinal P-glycoprotein. Holmstock, N., F.J. Gonzalez, M. Baes, P. Annaert, and P. Augustijns. Molecular Pharmaceutics, 2013. [Epub ahead of print]. PMID[23360470].
[PubMed]. HIV_0118-013113.

10. Interferon-inducible Cholesterol-25-hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol. Liu, S.Y., R. Aliyari, K. Chikere, G. Li, M.D. Marsden, J.K. Smith, O. Pernet, H. Guo, R. Nusbaum, J.A. Zack, A.N. Freiberg, L. Su, B. Lee, and G. Cheng. Immunity, 2013. 38(1): p. 92-105. PMID[23273844].
[PubMed]. HIV_0118-013113.

11. Design, Synthesis, Antimicrobial Activity and anti-HIV Activity Evaluation of Novel Hybrid Quinazoline-triazine Derivatives. Modh, R.P., E. De Clercq, C. Pannecouque, and K.H. Chikhalia. Journal of Enzyme Inhibition and Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23327639].
[PubMed]. HIV_0118-013113.

12. Benzene, Coumarin and Quinolinone Derivatives from Roots of Citrus hystrix. Panthong, K., Y. Srisud, V. Rukachaisirikul, N. Hutadilok-Towatana, S.P. Voravuthikunchai, and S. Tewtrakul. Phytochemistry, 2013. [Epub ahead of print]. PMID[23352239].
[PubMed]. HIV_0118-013113.

13. HIPdb: A Database of Experimentally Validated HIV Inhibiting Peptides. Qureshi, A., N. Thakur, and M. Kumar. PloS One, 2013. 8(1): p. e54908. PMID[23359817].
[PubMed]. HIV_0118-013113.

14. Selectivity of Kinases on the Activation of Tenofovir, an anti-HIV Agent. Varga, A., E. Graczer, L. Chaloin, K. Liliom, P. Zavodszky, C. Lionne, and M. Vas. European Journal of Pharmaceutical Sciences, 2013. 48(1-2): p. 307-315. PMID[23201309].
[PubMed]. HIV_0118-013113.

15. Dibenzocyclooctadiene Lignans and Norlignans from Fruits of Schisandra wilsoniana. Yang, G.Y., R.R. Wang, H.X. Mu, Y.K. Li, X.N. Li, L.M. Yang, Y.T. Zheng, W.L. Xiao, and H.D. Sun. Journal of Natural Products, 2013. [Epub ahead of print]. PMID[23327759].
[PubMed]. HIV_0118-013113.

16. Identification of a Small-molecule Inhibitor of HIV-1 Assembly That Targets the Phosphatidylinositol (4,5)-bisphosphate Binding Site of the HIV-1 Matrix Protein. Zentner, I., L.J. Sierra, A.K. Fraser, L. Maciunas, M.K. Mankowski, A. Vinnik, P. Fedichev, R.G. Ptak, J. Martin-Garcia, and S. Cocklin. ChemMedChem, 2013. [Epub ahead of print]. PMID[23361947].
[PubMed]. HIV_0118-013113.

ISI Web of Knowledge Citations

17. HIV-1 X4 Activities of Polycationic "Viologen" Based Dendrimers by Interaction with the Chemokine Receptor CXCR4: Study of Structure-Activity Relationship. Asaftei, S., D. Huskens, and D. Schols. Journal of Medicinal Chemistry, 2012. 55(23): p. 10405-10413. ISI[000312227300008].
[WOS]. HIV_0118-013113.

18. Development and Evaluation of a Thermosensitive Vaginal Gel Containing Raltegravir Plus Efavirenz Loaded Nanoparticles for HIV Prophylaxis. Date, A.A., A. Shibata, M. Goede, B. Sanford, K. La Bruzzo, M. Belshan, and C.J. Destache. Antiviral Research, 2012. 96(3): p. 430-436. ISI[000312518100019].
[WOS]. HIV_0118-013113.

19. A Pyrophosphatase Activity Associated with Purified HIV-1 Particles. Ducloux, C., M. Mougel, V. Goldschmidt, L. Didierlaurent, R. Marquet, and C. Isel. Biochimie, 2012. 94(12): p. 2498-2507. ISI[000312517800006].
[WOS]. HIV_0118-013113.

20. Structure-Activity Relationship Studies Using Peptide Arrays: The Example of HIV-1 Rev-integrase Interaction. Gabizon, R., O. Faust, H. Benyamini, S. Nir, A. Loyter, and A. Friedler. MedChemComm, 2013. 4(1): p. 252-259. ISI[000312547200036].
[WOS]. HIV_0118-013113.

21. A New Flavonoid from Daphne feddei and its anti-HIV-1 Activity. Hu, L., Q.F. Zhang, Y.Q. Ye, J. Zhong, Q. Hu, and Q.F. Hu. Asian Journal of Chemistry, 2012. 24(11): p. 5391-5392. ISI[000310771100137].
[WOS]. HIV_0118-013113.

22. Inhibition of HIV-1 Replication by RNA with a Microrna-like Function. Kato, K., T. Senoki, and H. Takaku. International Journal of Molecular Medicine, 2013. 31(1): p. 252-258. ISI[000312567000032].
[WOS]. HIV_0118-013113.

23. The BET Bromodomain Inhibitor JQ1 Activates HIV Latency through Antagonizing Brd4 Inhibition of Tat-transactivation. Li, Z.C., J. Guo, Y.T. Wu, and Q. Zhou. Nucleic Acids Research, 2013. 41(1): p. 277-287. ISI[000312889900055].
[WOS]. HIV_0118-013113.

24. Synthesis and anti-HIV Evaluation of Novel 1,2,4-Triazole Derivatives as Potential Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Li, Z.Y., Y. Cao, P. Zhan, C. Pannecouque, J. Balzarini, E. De Clercq, and X.Y. Liu. Letters in Drug Design & Discovery, 2013. 10(1): p. 27-34. ISI[000312830100005].
[WOS]. HIV_0118-013113.

25. Chemical Constituents of Sambucus L. Ma, Y.M. and H. Wu. Chinese Journal of Organic Chemistry, 2012. 32(11): p. 2063-2072. ISI[000312684100005].
[WOS]. HIV_0118-013113.

26. Synthesis, Screening and Computational Investigation of Pentacycloundecane-peptoids as Potent CSA-HIV PR Inhibitors. Makatini, M.M., K. Petzold, P.I. Arvidsson, B. Honarparvar, T. Govender, G.E.M. Maguire, R. Parboosing, Y. Sayed, M.E.S. Soliman, and H.G. Kruger. European Journal of Medicinal Chemistry, 2012. 57: p. 459-467. ISI[000312621700047].
[WOS]. HIV_0118-013113.

27. Pharmacophore Identification, Molecular Docking, Virtual Screening, and in Silico ADME Studies of Non-Nucleoside Reverse Transcriptase Inhibitors. Pirhadi, S. and J.B. Ghasemi. Molecular Informatics, 2012. 31(11-12): p. 856-866. ISI[000312693300009].
[WOS]. HIV_0118-013113.

28. Synthesis and Antiviral Evaluation of bis(POM) Prodrugs of (E)- [4 '-Phosphono-but-2 '-en-1 '-yl] Purine Nucleosides. Pradere, U., V. Roy, A. Montagu, O. Sari, M. Hamada, J. Balzarini, R. Snoeck, G. Andrei, and L.A. Agrofoglio. European Journal of Medicinal Chemistry, 2012. 57: p. 126-133. ISI[000312621700013].
[WOS]. HIV_0118-013113.

29. Functional Characterization of the Recombinant HIV-neutralizing Monoclonal Antibody 2F5 Produced in Maize Seeds. Sabalza, M., L. Madeira, C. van Dolleweerd, J.K. Ma, T. Capell, and P. Christou. Plant Molecular Biology, 2012. 80(4-5): p. 477-488. ISI[000312133800009].
[WOS]. HIV_0118-013113.

30. Synthesis, Complexation and Biological Activity of New Isatin Schiff Bases. Sallam, S.A., E.S.I. Ibrahim, and M.I. Anwar. Journal of the Chilean Chemical Society, 2012. 57(4): p. 1482-1491. ISI[000312620900030].
[WOS]. HIV_0118-013113.

31. The Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview. Wang, W., S.X. Wang, and H.S. Guan. Marine Drugs, 2012. 10(12): p. 2795-2816. ISI[000312607700014].
[WOS]. HIV_0118-013113.

32. Inhibition of Reverse Transcriptase Activity Increases Stability of the HIV-1 Core. Yang, Y., T. Fricke, and F. Diaz-Griffero. Journal of Virology, 2013. 87(1): p. 683-687. ISI[000312455500061].
[WOS]. HIV_0118-013113.